Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/2007
06/28/2007WO2007000779A3 Pharmaceutical sustained release compositions and processes thereof
06/28/2007WO2006071685A3 Antimicrobial combination therapy comprising an antibiotic and toxic compound selected from dna damaging agents, alkylating agents, heavy metal containing compounds and chelating agents
06/28/2007WO2004075850A3 Polyvalent immunogen
06/28/2007US20070149565 Nelfinavir conjugates and antibodies useful in immunoassay
06/28/2007US20070149540 Crystal of 6-fluoro-1-methyl-7-[4-(5-methyl-2-oxo-1,3-dioxolen-4-yl)-methyl-1-piperazinyl]-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid acetonitrile solvate; antibacterial activity; preferentially precipitated by controlling supersaturation concentration in crystalization using acetonitrile
06/28/2007US20070149531 Antiviral agents
06/28/2007US20070149530 Antiviral agents
06/28/2007US20070149520 HCV Inhibitors And Methods Of Using Them
06/28/2007US20070149488 Tetracycline Derivatives and Methods of Use Thereof
06/28/2007US20070148744 inhibitors of vacuolar-type H+-ATPase; antibiotic; (3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16- [(1S,2R,3S)-3-[(2R,4R,5S,6R)-2,4-dihydroxy-6- isopropyl-5-methyl-2-tetrahydropyranyl]-2- hydroxy-1-methylbutyl]-8-hydroxy-3,15- dimethoxy-5,7,9,11-tetramethyl-1- oxacyclohexadeca-3,5,11,13-tetraen-2-one
06/28/2007US20070148734 Hyaluronic acid mediated adenoviral transduction
06/28/2007US20070148731 Expression control sequence cassette; a nucleotide sequence of a lac operator sequence to which a lacI repressor protein specifically binds a mutated lac; modification of the nucleotide sequence within a T5 promoter/lac operator expression control sequence provides a stable promoter/operator
06/28/2007US20070148708 Protease inhibitor conjugates and antibodies useful in immunoassay
06/28/2007US20070148688 Novel human enzymes of the metalloprotease family
06/28/2007US20070148629 Composition for the preservation of viruses
06/28/2007US20070148264 Agent for the prevention and/or treatment of septicemia
06/28/2007US20070148256 Pharmacologic-functioning water and usage of the same
06/28/2007US20070148254 Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres
06/28/2007US20070148236 Pharmaceutical Compositions of Adsorbates of Amorphous Drug
06/28/2007US20070148235 Pharmaceutical composition
06/28/2007DE102005061290A1 Verfahren zur Herstellung von Antibiotikum-/Antibiotika-Partikeln und deren Verwendung A process for producing antibiotic / antibiotics particles and their use
06/28/2007DE102005059279A1 Fungizid oder antimykotisch wirkende Verbindungen Fungicide or antifungal acting compounds
06/28/2007DE102005053926B3 Use of antibacterial agent from mixture of plant drugs, comprises Rumex acetosa L.-family, Rumicis herba, Verbena officinalis, Sambucus nigra, Primula veris and Gentiana lutea, e.g. to treat infection on topical skin and mucous membrane
06/28/2007CA2816182A1 Pneumococcal polysaccharide conjugate vaccine
06/28/2007CA2808919A1 Streptococcus pneumoniae capsular saccharide vaccine
06/28/2007CA2634911A1 Neisseria meningitidis vaccines and their use
06/28/2007CA2634898A1 Immunogenic composition
06/28/2007CA2634644A1 8-pyrazinyl-5-spiropyrimidinetrione-oxazinoquinoline derivatives as antibacterial agents
06/28/2007CA2634468A1 Spiroketals
06/28/2007CA2634377A1 Method of eliciting immune response
06/28/2007CA2634362A1 Organophosphoric derivatives useful as anti-parasitic agents
06/28/2007CA2634163A1 Compositions and methods of modulating the immune response
06/28/2007CA2634116A1 Anti-ilt7 antibody
06/28/2007CA2634056A1 Amorphous form of 1,2-dihydropyridine compound
06/28/2007CA2633742A1 Composition
06/28/2007CA2633713A1 Epha2 bite molecules and uses thereof
06/28/2007CA2633010A1 Histone deacetylase inhibitors for enhancing activity of antifungal agents
06/28/2007CA2632842A1 Process for preparation of water-soluble azole prodrugs
06/28/2007CA2632449A1 Alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof
06/28/2007CA2626220A1 Novel substituted pyrazinone derivatives for use in mch-1 mediated diseases
06/27/2007EP1801218A2 Nucleic acids and proteins from streptococcus pneumoniae
06/27/2007EP1801217A1 Group A streptococcal vaccines
06/27/2007EP1801209A1 Modified human hepatitis c virus genomic rna having autonomous replicative competence
06/27/2007EP1801120A1 Co-crystalline complex of IGF-1 and methods of identifying indirect agonists of IGF-1 using the same
06/27/2007EP1801106A2 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
06/27/2007EP1800713A1 Use of alkoxylates of monovalent and polyvalent alcohols or a derivative thereof as substituent antibioticum in animal feed
06/27/2007EP1800697A2 Pharmaceutical compound, containing a stabilised mRNA which is optimised for translation in its coded areas
06/27/2007EP1800692A1 Novel adjuvant for subunit or component vaccines
06/27/2007EP1800687A2 Anionic polymers as toxin binders and antibacterial agents
06/27/2007EP1800686A2 Anionic polymers as toxin binders and antibacterial agents
06/27/2007EP1800684A1 Novel alkyl phospholipid derivatives and uses thereof
06/27/2007EP1800676A1 Cancer chemotherapy
06/27/2007EP1799866A2 Modulating mxa expression
06/27/2007EP1799718A1 Vaccine
06/27/2007EP1799696A2 Phosphoindoles as hiv inhibitors
06/27/2007EP1799682A2 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof
06/27/2007EP1799677A1 Oxazolidinone derivatives as antimicrobials
06/27/2007EP1799674A1 New piperidine antibiotics
06/27/2007EP1799663A1 Modulators of hcv replication
06/27/2007EP1799257A1 The use of an inhibitor of heterotetrameric annexin 2 for treating viral infections
06/27/2007EP1799253A1 Multivalent canine vaccines against leptospira bratislava and other pathogens
06/27/2007EP1799252A1 Antibody production method
06/27/2007EP1799222A2 Compounds that inhibit replication of human immunodeficiency virus
06/27/2007EP1799218A1 Hcv inhibiting bi-cyclic pyrimidines
06/27/2007EP1799213A2 Novel curcumin analogues and uses thereof
06/27/2007EP1583967B1 Method for inhibiting the replication of herpes viruses
06/27/2007EP1504004B1 Substituted pyrazolopyrimidines
06/27/2007EP1392259B1 Delivery of erectile dysfunction drugs through an inhalation route
06/27/2007EP1368312B1 Benzo[f]isoindole derivatives with affinity to the ep4 receptor
06/27/2007EP1305419B1 Modulation by il-tif/interleukin-21
06/27/2007EP1284973B1 Inhibitors of alpha l beta 2 mediated cell adhesion
06/27/2007EP1272459B1 7- and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
06/27/2007EP1219630B1 Immunopotentiating compositions
06/27/2007EP1212063B1 Topical azathioprine for the treatment of oral autoimmune diseases
06/27/2007EP0980387B1 Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays
06/27/2007EP0863903B1 Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof
06/27/2007CN1989146A Sulfated oligosaccharide derivatives
06/27/2007CN1989141A Bicyclic heterocycles as HIV integrase inhibitors
06/27/2007CN1989137A 3- '4- {6-substituted alkanoyl) pyridin-3-yl} -3-phenyl! -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents
06/27/2007CN1989136A 3-[4-(6-{4, 5-dihydroisoxazol -3-yl} pyridin-3-yl)- 3-phenyl]-5 -(1h-1, 2, 3-triazol -1-ylmethyl)-1, 3-oxazolidin- 2-ones as antibacterial agents
06/27/2007CN1989135A 3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) -5-triazol-1-ylmethyloxazolidin-2-one derivaives as mao inhibitors for the treatment of bacterial infections
06/27/2007CN1989134A 3- {4- (pyridin-3-yl) phenyl} -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents
06/27/2007CN1989122A Novel cylopenta[b]benzofuran derivatives and the utilization thereof
06/27/2007CN1988917A Phep, an amino acid permease of staphylococcus aureus
06/27/2007CN1988894A Preventive for the onset of liver cancer comprising quinone compound as the active ingredient
06/27/2007CN1988887A Injectable pharmaceutical suspension comprising posaconazole
06/27/2007CN1987465A Immune fluorescence grouping method
06/27/2007CN1986794A Light and heavy chain variable region gene of monoclonal antibody for resisting protective anthrax bacillus antigen and its application
06/27/2007CN1986569A Humanized respiratory syncytial virus-resisting neutralizing gentically engineered Fab antibody
06/27/2007CN1986562A Polypeptide segment capable of enhancing animal's antibody response and its application
06/27/2007CN1986553A Precursor medicine of acyclic nucleoside phosphonic acid
06/27/2007CN1986521A Synthesis process of peramivir as medicine for antagonizing influenza and bird flu virus
06/27/2007CN1986520A Preparing process of optically active long chain N-Boc-amino acid with end olefinic bond
06/27/2007CN1985994A Improved enteric medicine composition with mycophenolate
06/27/2007CN1985992A New scheme of combining cell factor fusion protein (IL 2/FC) and compound Chinese medicine 861 for enhancing immune response of HB vaccine and breaking immune tolerance of HBV
06/27/2007CN1985988A Novel medicine composition for treating hepatic diseases
06/27/2007CN1985987A Medicine composition of glycyrrhizic acid or its salt and reduced glutathione
06/27/2007CN1985975A Chinese medicine for treating tinea pedis by soaking feet
06/27/2007CN1985969A Jinqing detoxicating preparation and new preparing process
06/27/2007CN1985960A Slow released capsule of clarithromycin and bletilla tuber glue for animal and birs
1 ... 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 ... 1798